Ultragenyx Pharmaceutical(MX:RARE)
MX$256.000.00 (0.00%)
MX:RARE
Ultragenyx Pharmaceutical earnings date
MX$256.00
At close:0.00 (0.00%)
Ultragenyx Pharmaceutical (RARE) Q2 2020 Earnings Report
1 Followers
MX:RARE Q2 2020 EPS Results
- Actual EPS
- MXN 7.62
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -MXN 31.97
MX:RARE Q2 2020 Revenue Results
- Actual Revenue
- MXN 1.15B
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +155.53%
Earnings Announcement Details
- Quarter
- Q2 2020
- Date
- 07/30/2020
- Time
- After Close
- Conference Call
- Thursday, July 30, 2020
MX:RARE Upcoming Earnings
Ultragenyx Pharmaceutical's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q2 2020 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2020 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2020 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:RARE Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | 44.48- | -23.98 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | -20.45-21.56 | -33.65 | 35.91% (+12.08) | |
| Aug 04, 2026 | 2026 (Q2) | -23.09-16.73 | -21.75 | 23.08% (+5.02) | |
| May 05, 2026 | 2026 (Q1) | -27.66-34.20 | -29.19 | -17.20% (-5.02) | |
| Feb 12, 2026 | 2025 (Q4) | -20.32-23.98 | -25.84 | 7.19% (+1.86) | |
| Nov 04, 2025 | 2025 (Q3) | -22.94-33.65 | -26.03 | -29.29% (-7.62) | |
| Aug 05, 2025 | 2025 (Q2) | -24.11-21.75 | -28.26 | 23.03% (+6.51) | |
| May 06, 2025 | 2025 (Q1) | -29.71-29.19 | -37.74 | 22.66% (+8.55) | |
| Feb 13, 2025 | 2024 (Q4) | -24.31-25.84 | -28.26 | 8.55% (+2.42) | |
| Nov 05, 2024 | 2024 (Q3) | -27.59-26.03 | -41.45 | 37.22% (+15.43) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
